Extrahepatic autoimmune manifestations of chronic hepatitis C virus infection

Annals of Hepatology

Volumn 5, Issue 3, 2006, Pages 161-163

  García Carrasco, Mario ^a,b   Escárcega, Ricardo O ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RHEUMATOID FACTOR;

ANTIPHOSPHOLIPID SYNDROME; ASCITES; AUTOIMMUNE DISEASE; BLOOD DONOR; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; FLAVIVIRUS; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SYSTEM; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREVALENCE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33748938707     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)32000-9     Document Type: Editorial

References (24)

1. 1. Flamm SI. Chronic Hepatitis C Virus Infection. JAMA 2003; 289: 2413-17.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
3. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis c virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 41-63.
4. Memon MI, Memom MA. Hepatitis C. An epidemiological review. J viral Hepat 2002; 9: 84-100.
5. Mendez-Sánchez N, Baptista-González H, Sánchez- Gómez RH, Bordes-Aznar J, Uribe-Equivel M. The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City. Salud Publica Mex 1999; 41: 475-8.
6. Ladron-de Guevara L, Gómez N, Vazquez-Cantarell M, Garcia-Mendez S, Di Silvio M. Prevalence of and risk factors for hepatitis C in blood donors. Rev Gastroenterol Mex 2002; 67: 11-6.
7. Benitez-Arvizu G, Cortez-Gomez R, Novelo-Garza BA, Malagon-Martinez A, Guerra-Marquez A, Alvarado-Maldonado M del C, et al. Prevalence of hepatitis C virus in the blood bank at Centro Medico Nacional La Raza. Rev Med Inst Mex Seguro Soc 2006; 44: 227-33.
8. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-33.
9. Vera de León L, Juarez-Navarro JA, Díaz-Gómez M, Méndez-Navarro J, Chirino Sprung RA, Dehesa-Violante M, et al. Epidemiologic and situational panorama of hepatitis C in México. Rev Gastroenterol Mex 2005; 70: 25-32.
10. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 2003; 325: 135-48.
11. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease: review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
12. Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, et al. Lichen planus and hepatitis C virus: a multicenter study of patients with oral lesions and a systematic review. Br J Rheumatol 2004; 151: 1172-81.
13. Ramos-Casals M, Trejo O, García-Carrasco M, Font J. Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology 2003; 42: 818-28.
14. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
15. Ramos-Casals M, García-Carrasco M, Brito-Zerón MP, Cervera R, Font J. Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus. Autoimmunity Reviews 2002; 1: 238-43.
16. Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, et al. Sjögren's syndrome associated with hepatitis C virus: a mulitcenter analysis of 137 patients. Medicine (Baltimore) 2005; 84: 81-9.
17. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Sjögren's syndrome and hepatitis C virus. Clinical Rheumatology 1999; 18: 93-100.
18. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, et al. Hepatitis C virus infection mimicking primary Sjögren syndrome A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8.
19. Roca B. Manifestaciones extrahepáticas de la infección por el virus de la hepatitis C. Enferm Infecc Microbiol Clin 2004; 22: 467-70.
20. Ramos-Casals M, Font J, Garcia-Carrasco M, Cervera R, Jimenez S, Trejo O, et al. Hepatitis C virus Infection mimicking systemic lupus erithematosus, study of hepatitis C virus infection in a series of 134 spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2801-6.
21. Sthoeger ZM, Fogel M, Smirov A, Ergas D, Lurie Y, Bass DD, et al. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C virus infection. Ann Rheum Dis 2000; 59: 483-86.
22. Ramos-Casals M, Cervera R, Lagrutta M, Medina F, García-Carrasco M, de la Red G, et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (Hepatitis C virus/HIV infection): Description of 82 cases. Clin Infect Dis 2004; 38: 1009-16.
23. Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E,. The case for hepatitis C artritis. Semin Arhtritis Rheum 2004; 33: 375-87.
24. Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C virus infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6: R137-41.